Skip links

Author: Diana

Remdesivir results ‘promising’ in Medical Center clinical trial

The University of Rochester Medical Center has been participating in a clinical trial testing the safety and efficacy of the antiviral drug remdesivir. According to preliminary results released by the National Institutes of Health, the drug is now showing promise in treating adults diagnosed with COVID-19.  The study is led by

Spring 2020 TDF Round Cancelled

Given the changing circumstances due to the Covid-19 pandemic, URVentures has decided to cancel the Spring 2020 round of the Technology Development Fund. Please direct any questions to the Fund’s Director. Omar Bakht Fund Director Omar_Bakht@urmc.rochester.edu

Applications Due Feb. 17 for NSF I-Corps Node Short Course at UR

The NSF I-Corps Upstate New York (UNY) Node is offering a short course program for researchers interested in exploring the market potential of their work and learning entrepreneurial skills. Short Courses—geared toward faculty, doctoral candidates, and postdocs—are offered at no cost to participants and consist

2020 Medical Device Innovation Challenge

CNY Biotech Accelerator, a division of the State University of New York Upstate Medical University, located in Syracuse, NY, is seeking medical device innovators for its annual 6-month grant-funded Medical Device Innovation Challenge (MDIC). Applications from US-based innovators are accepted January 1 – May 31,

2019 EDI Medicines Award Program is Now Open

The University of Rochester has joined together with the University of Buffalo and Roswell Park Comprehensive Cancer Center to form Empire Discovery Institute, a new drug discovery partnership. EDI aims to convert the institutions’ scientific breakthroughs into viable pharmaceuticals for commercialization and to strengthen the

Needle-Free Flu Vaccine Patch Effective in Early Study

A new needle-free flu vaccine patch revved up the immune system much like a traditional flu shot without any negative side effects, according to a study published in the Journal of Investigative Dermatology. Though the research is in the early stages (the patch hasn’t been tested in

New Funding Boosts URMC Biotech Start-Up for Neurological Disorders

Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC) has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders. The funding represents the largest-ever investment in

VPG Medical featured in Rochester Business Journal

University of Rochester start-up, VPG Medical, was recently featured in the Rochester Business Journal: VPG Medical uses unconventional tech for heart care Among the companies in the Luminate NY accelerator, VPG Medical Inc. is a bit unique. While most companies in the accelerator are based